Connection
Nicholas Cost to Molecular Targeted Therapy
This is a "connection" page, showing publications Nicholas Cost has written about Molecular Targeted Therapy.
|
|
Connection Strength |
|
 |
|
 |
|
0.668 |
|
|
|
-
Cost NG, Krabbe LM, Bagrodia A, Margulis V. The use of preoperative targeted molecular therapy to allow nephron sparing for T1b tumors. Curr Opin Urol. 2013 Sep; 23(5):411-7.
Score: 0.363
-
Cost NG, Delacroix SE, Sleeper JP, Smith PJ, Youssef RF, Chapin BF, Karam JA, Culp S, Abel EJ, Brugarolas J, Raj GV, Sagalowsky AI, Wood CG, Margulis V. The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus. Eur Urol. 2011 Jun; 59(6):912-8.
Score: 0.305